NasdaqGM:OABILife Sciences
OmniAb (OABI) FY 2025 Loss Of US$64.8m Keeps Profitability Narrative Under Pressure
OmniAb FY 2025 earnings snapshot
OmniAb (NasdaqGM:OABI) has wrapped up FY 2025 with fourth quarter revenue of US$8.4 million, a basic EPS loss of US$0.11, and a net loss of US$14.2 million, putting hard numbers around a year where growth expectations and ongoing losses are both in focus. Over recent periods, the company has seen quarterly revenue range from US$2.2 million to US$10.8 million and basic EPS move between a loss of US$0.11 and a loss of US$0.17. This gives investors a clear view...